Vanguard Group Inc. Acquires 317,538 Shares of Corteva, Inc. $CTVA

Vanguard Group Inc. boosted its holdings in Corteva, Inc. (NYSE:CTVA) by 0.4% during the 4th quarter, Holdings Channel.com reports. The fund owned 80,536,951 shares of the company’s stock after purchasing an additional 317,538 shares during the quarter. Vanguard Group Inc. owned 0.12% of Corteva worth $5,398,392,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. State Street Corp increased its stake in Corteva by 3.6% in the 3rd quarter. State Street Corp now owns 35,280,805 shares of the company’s stock valued at $2,386,041,000 after buying an additional 1,230,074 shares during the last quarter. Franklin Resources Inc. increased its stake in Corteva by 5.9% in the 3rd quarter. Franklin Resources Inc. now owns 18,731,627 shares of the company’s stock valued at $1,266,820,000 after buying an additional 1,051,389 shares during the last quarter. Northern Trust Corp increased its stake in Corteva by 1.8% in the 3rd quarter. Northern Trust Corp now owns 11,169,284 shares of the company’s stock valued at $755,379,000 after buying an additional 194,728 shares during the last quarter. Legal & General Group Plc grew its position in shares of Corteva by 14.3% during the 3rd quarter. Legal & General Group Plc now owns 5,753,982 shares of the company’s stock valued at $389,142,000 after acquiring an additional 720,469 shares during the period. Finally, Alliancebernstein L.P. grew its position in shares of Corteva by 3.0% during the 3rd quarter. Alliancebernstein L.P. now owns 4,381,340 shares of the company’s stock valued at $296,310,000 after acquiring an additional 125,690 shares during the period. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Insider Transactions at Corteva

In other Corteva news, insider Brian Titus sold 8,311 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider directly owned 8,090 shares in the company, valued at $619,289.50. This represents a 50.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.15% of the stock is owned by corporate insiders.

Corteva Stock Down 0.3%

CTVA opened at $79.53 on Tuesday. The company has a 50 day moving average of $80.19 and a 200 day moving average of $71.82. The company has a market cap of $53.39 billion, a PE ratio of 50.34, a price-to-earnings-growth ratio of 2.74 and a beta of 0.68. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $85.63. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting the consensus estimate of $0.22. The company had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. Corteva’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same period last year, the firm earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts expect that Corteva, Inc. will post 3.62 EPS for the current year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were issued a $0.18 dividend. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is 45.57%.

Analysts Set New Price Targets

A number of research firms have recently weighed in on CTVA. Jefferies Financial Group increased their target price on shares of Corteva from $85.00 to $95.00 and gave the company a “buy” rating in a research report on Monday, March 2nd. Weiss Ratings reissued a “hold (c)” rating on shares of Corteva in a research report on Wednesday, April 22nd. Zacks Research downgraded shares of Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. Royal Bank Of Canada increased their target price on shares of Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research report on Friday. Finally, Citigroup increased their target price on shares of Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a research report on Thursday, February 5th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, Corteva has a consensus rating of “Moderate Buy” and a consensus price target of $85.19.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.